Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Cureus|March 21, 2022
Reirradiation for Rare Head and Neck Cancers: Orbit, Auditory Organ, and Salivary GlandsHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.Journal of Radiation Research|December 4, 2010
Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomesNaohiro Kodani, Hideya Yamazaki, Takuji Tsubokura, et al.Journal of Radiation Research|January 8, 2013
Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-institution experienceKana Kobayashi, Koji Okihara, Tsuyoshi Iwata, et al.Journal of Medical Case Reports|June 3, 2014
Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case reportTakuya Nishimura, Hideya Yamazaki, Kazuki Iwama, et al.Scientific Reports|January 8, 2022
Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9-10 clinical localized prostate cancerHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.Journal of Radiation Research|January 25, 2014
Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitisNorihiro Aibe, Hideya Yamazaki, Satoaki Nakamura, et al.Cancers|April 30, 2021
Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated RadiotherapyHideya Yamazaki, Gen Suzuki, Koji Masui, et al.Anticancer Research|December 16, 2014
Frequency and predisposing factors for interfractional rectal displacement requiring repeated precaution in prostate cancer patients treated with image-guided intensity-modulated radiation therapyKazuki Iwama, Hideya Yamazaki, Takuya Nishimura, et al.Scientific Reports|February 22, 2023
Reirradiation for local recurrence of oral, pharyngeal, and laryngeal cancers: a multi-institutional studyHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.Cancers|January 11, 2022
Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate CancerHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.Pageof 7